昭衍新药实控人周志文减持1010.37万股公司股份

Core Viewpoint - The company announced that its actual controller, Zhou Zhiwen, reduced his shareholding in the company, impacting the overall ownership structure [1] Group 1: Shareholding Changes - Zhou Zhiwen reduced his shareholding by a total of 4.1537 million shares through centralized bidding, accounting for 0.55% of the company's total share capital [1] - Additionally, he reduced his shareholding by 5.95 million shares through block trading, representing 0.79% of the company's total share capital [1] - Following these transactions, the combined shareholding of Zhou Zhiwen and Feng Yuxia decreased from 32.27% to 30.93%, crossing the 1% threshold for equity changes [1]